BioNTech News

BioNTech | SC 13D: Statement of acquisition of beneficial ownership by individuals-BioNTech SE(12.5%)

Feb 21 17:07 ET

BioNTech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Prof. Ugur Sahin, M.D.(17.4%),Medine GmbH(17.0%)

Feb 14 07:31 ET

BioNTech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-ATHOS KG(43.8%),AT Impf GmbH(43.8%), etc.

Feb 7 17:08 ET

BioNTech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals(Amendment)-Prof. Ugur Sahin, M.D.(17.4%),Medine GmbH(17.0%)

Feb 21, 2023 19:17 ET

BioNTech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals(Amendment)-AT Impf GmbH(43.5%),Thomas Maier(43.5%), etc.

Feb 14, 2023 06:06 ET

BioNTech | D: Filing D

Apr 14, 2022 11:11 ET

BioNTech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Medine GmbH(17.11%),Prof. Ugur Sahin, M.D.(17.11%)

Feb 14, 2022 16:23 ET

BioNTech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-ATHOS KG(43.8%),AT Impf GmbH(43.8%), etc.

Feb 11, 2022 17:01 ET

BioNTech | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)

Feb 16, 2021 16:06 ET

BioNTech | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)

Feb 16, 2021 16:00 ET

BioNTech | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)

Feb 16, 2021 06:21 ET

BioNTech | D: Filing D

Sep 17, 2020 08:26 ET

BioNTech | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions

Feb 14, 2020 14:11 ET

BioNTech | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions

Feb 13, 2020 12:53 ET

BioNTech | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions

Feb 12, 2020 16:17 ET

BioNTech | SC 13D: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities

Jan 23, 2020 16:01 ET